Converting tumors into vaccine manufacturing factories: DC recruitment, activation and clinical responses with a flt3L-primed in situ vaccine for low-grade lymphoma [nct01976585]

Detalles Bibliográficos
Autores principales: Bhardwaj, Nina, Merad, Miriam, Kim-Schulze, Seunghee, Crowley, Beth, Davis, Thomas, Keler, Tibor, Salazar, Andres, Brody, Joshua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288649/
http://dx.doi.org/10.1186/2051-1426-2-S3-P45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288649/
http://dx.doi.org/10.1186/2051-1426-2-S3-P45

Ejemplares similares